Home / Lenalidomide / Czechia
CZ ATC L04AX04 · updated 2 Nov 2026
Lenalidomide shortage in Czechia
Is there a Lenalidomide shortage in Czechia?
Yes. As of 2 Nov 2026, 5 Lenalidomide products are reported short in Czechia, the first since 31 Dec 2025. The company estimate for the return is 18 Nov 2026 (latest 1 Jan 2027). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Switzerland, Norway, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | LENALIDOMIDE GRINDEKS 10MG 10MG CPS DUR 21 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | LENALIDOMIDE GRINDEKS 15MG 15MG CPS DUR 21 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | LENALIDOMIDE GRINDEKS 25MG 25MG CPS DUR 21 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | LENALIDOMIDE GRINDEKS 5MG 5MG CPS DUR 21 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | LENALIDOMID SANDOZ 5MG 5MG CPS DUR 21 | Sandoz s.r.o., Praha | 19 Aug 2026 | 18 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.